The redox cofactor F420 protects mycobacteria from diverse antimicrobial compounds and mediates a reductive detoxification system.

A defining feature of mycobacterial redox metabolism is the use of an unusual deazaflavin cofactor, F This cofactor enhances the persistence of environmental and pathogenic mycobacteria, including following antimicrobial treatment, though the molecular basis for this remains to be understood. In this work, we explored our hypothesis that F enhances persistence by serving as a cofactor in antimicrobial-detoxifying enzymes. To test this, we performed a series of phenotypic, biochemical, and analytical chemistry studies in relation to the model soil bacterium Mycobacterium smegmatis Mutant strains unable to synthesize or reduce F were found to be more susceptible to a wide range of antibiotic and xenobiotic compounds. Compounds from three classes of antimicrobial compounds traditionally resisted by mycobacteria inhibited growth of F mutant strains at subnanomolar concentrations, namely furanocoumarins (e.g. methoxsalen), arylmethanes (e.g. malachite green), and quinone analogues (e.g. menadione). We demonstrated that promiscuous FH-dependent reductases directly reduce these compounds by a mechanism consistent with hydride transfer. Moreover, M. smegmatis strains unable to make FH lost the capacity to reduce and detoxify representatives of the furanocoumarin and arylmethane compound classes in whole-cell assays. By contrast, mutant strains were only slightly more susceptible to clinical antimycobacterials and this appeared to be due to indirect effects of F loss-of-function (e.g. redox imbalance) rather than loss of a detoxification system. Together, these data show that F enhances antimicrobial resistance in mycobacteria and suggest that one function of the FH-dependent reductases is to broaden the range of natural products that mycobacteria and possibly other environmental actinobacteria can reductively detoxify.,This study reveals that a unique microbial cofactor, F, is critical for antimicrobial resistance in the environmental actinobacterium Mycobacterium smegmatis We show that a superfamily of redox enzymes, the FH-dependent reductases, can reduce diverse antimicrobials in vitro and in vivo M. smegmatis strains unable to make or reduce F become sensitive to inhibition by these antimicrobial compounds. This suggests that mycobacteria have harnessed the unique properties of F to reduce structurally diverse antimicrobials as part of the antibiotics arm race. The FH-dependent reductases that facilitate this process represent a new class of antimicrobial-detoxifying enzymes with potential applications in bioremediation and biocatalysis.